BIOMAT Database Logo BIOMAT Database Logo

Antibodies to topoisomerase I in sera from patients with scleroderma. 1987

J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw

In a study of sera from patients with scleroderma, it was found that Scl-70 is the abundant nuclear enzyme DNA topoisomerase I.

UI MeSH Term Description Entries
D009687 Nuclear Proteins Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus. Nucleolar Protein,Nucleolar Proteins,Nuclear Protein,Protein, Nuclear,Protein, Nucleolar,Proteins, Nuclear,Proteins, Nucleolar
D009698 Nucleoproteins Proteins conjugated with nucleic acids. Nucleoprotein
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
Inhibition of topoisomerase I by antibodies in sera from scleroderma patients.
December 1986, FEBS letters,
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
Comparison between counterimmunoelectrophoresis and double radial immunodiffusion in the detection of antibodies to topoisomerase I in sera from scleroderma patients.
January 1988, Bollettino dell'Istituto sieroterapico milanese,
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
December 1993, Journal of immunology (Baltimore, Md. : 1950),
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
Antibodies to HTLV-I in sera from patients with connective tissue diseases.
January 1989, Annals of the rheumatic diseases,
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
[Anti-idiotypic antibodies to topoisomerase I in serum from patients with autoimmune diseases].
January 1991, Doklady Akademii nauk SSSR,
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
[The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma].
January 1992, Terapevticheskii arkhiv,
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
[Interactions of sera from patients with autoimmune diseases with cDNA expressed fragment of topoisomerase I and monoclonal antibodies against enzyme].
December 1990, Biulleten' eksperimental'noi biologii i meditsiny,
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
Autoantibody to RNA polymerase I in scleroderma sera.
January 1987, The Journal of clinical investigation,
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
A recombinant topoisomerase I used for autoantibody detection in sera from patients with systemic sclerosis.
April 1990, Clinical and experimental immunology,
J H Shero, and B Bordwell, and N F Rothfield, and W C Earnshaw
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease.
September 1998, Chest,
Copied contents to your clipboard!